Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

J. Subramanian; J. Jaal; I. Kudaba; K. Nikolov; D. Radosavljevic; T. Csoszi; J. Xiao; J. Horton; R. K. Malik; M. D. Gomez

doi:10.1016/j.jtho.2020.10.145

Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

J. Subramanian, J. Jaal, I. Kudaba, K. Nikolov, D. Radosavljevic, T. Csoszi, J. Xiao, J. Horton, R. K. Malik, M. D. Gomez

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	MO01.41
Pages (from-to)	S33
Journal	Journal of Thoracic Oncology
Volume	16
Issue number	1
DOIs	https://doi.org/10.1016/j.jtho.2020.10.145
Publication status	Published - Jan 2021
Externally published	Yes
Event	2020 North America Conference on Lung Cancer - online, United States Duration: 16 Oct 2020 → 17 Oct 2020 https://naclc2020.iaslc.org/ https://naclc2020.iaslc.org/program-at-a-glance/

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jtho.2020.10.145

Cite this

Subramanian, J., Jaal, J., Kudaba, I., Nikolov, K., Radosavljevic, D., Csoszi, T., Xiao, J., Horton, J., Malik, R. K., & Gomez, M. D. (2021). Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer. Journal of Thoracic Oncology, 16(1), S33. Article MO01.41. https://doi.org/10.1016/j.jtho.2020.10.145

@article{90ed4fbfab02422eba35ea2bb6b89ce4,

title = "Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer",

author = "J. Subramanian and J. Jaal and I. Kudaba and K. Nikolov and D. Radosavljevic and T. Csoszi and J. Xiao and J. Horton and Malik, {R. K.} and Gomez, {M. D.}",

year = "2021",

month = jan,

doi = "10.1016/j.jtho.2020.10.145",

language = "English",

volume = "16",

pages = "S33",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "International Association for the Study of Lung Cancer",

number = "1",

note = "2020 North America Conference on Lung Cancer ; Conference date: 16-10-2020 Through 17-10-2020",

url = "https://naclc2020.iaslc.org/, https://naclc2020.iaslc.org/program-at-a-glance/",

}

Subramanian, J, Jaal, J, Kudaba, I, Nikolov, K, Radosavljevic, D, Csoszi, T, Xiao, J, Horton, J, Malik, RK & Gomez, MD 2021, 'Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer', Journal of Thoracic Oncology, vol. 16, no. 1, MO01.41, pp. S33. https://doi.org/10.1016/j.jtho.2020.10.145

TY - JOUR

T1 - Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

AU - Subramanian, J.

AU - Jaal, J.

AU - Kudaba, I.

AU - Nikolov, K.

AU - Radosavljevic, D.

AU - Csoszi, T.

AU - Xiao, J.

AU - Horton, J.

AU - Malik, R. K.

AU - Gomez, M. D.

PY - 2021/1

Y1 - 2021/1

UR - https://www.jto.org/article/S1556-0864(20)31011-X/fulltext

U2 - 10.1016/j.jtho.2020.10.145

DO - 10.1016/j.jtho.2020.10.145

M3 - Meeting Abstract

SN - 1556-0864

VL - 16

SP - S33

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 1

M1 - MO01.41

T2 - 2020 North America Conference on Lung Cancer

Y2 - 16 October 2020 through 17 October 2020

ER -

Using an Exploratory Composite Endpoint to Evaluate the Myelopreservation Benefits of Trilaciclib in Patients with Small Cell Lung Cancer

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Cite this